DALLAS FIBROID CENTER Trademark
Trademark Overview
On Friday, April 7, 2023, a trademark application was filed for DALLAS FIBROID CENTER with the United States Patent and Trademark Office. The USPTO has given the DALLAS FIBROID CENTER trademark a serial number of 97877814. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by Texas Endovascular Associates, PLLC. The DALLAS FIBROID CENTER trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical services, namely, treatment of adenomyosis and leiomyoma
General Information
Serial Number | 97877814 |
Word Mark | DALLAS FIBROID CENTER |
Filing Date | Friday, April 7, 2023 |
Status | 700 - REGISTERED |
Status Date | Tuesday, May 28, 2024 |
Registration Number | 7403796 |
Registration Date | Tuesday, May 28, 2024 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Medical services, namely, treatment of adenomyosis and leiomyoma |
NOT AVAILABLE | "FIBROID CENTER" |
Classification Information
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, May 2, 2023 |
Primary Code | 044 |
First Use Anywhere Date | Friday, June 23, 2023 |
First Use In Commerce Date | Friday, June 23, 2023 |
Trademark Owner History
Party Name | Texas Endovascular Associates, PLLC |
Party Type | 30 - Original Registrant |
Legal Entity Type | 16 - Limited Liability Company |
Address | BELLAIRE, TX 77401 |
Party Name | Texas Endovascular Associates, PLLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | BELLAIRE, TX 77401 |
Trademark Events
Event Date | Event Description |
Tuesday, April 11, 2023 | NEW APPLICATION ENTERED |
Tuesday, May 2, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, January 11, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, January 11, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, January 11, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, April 2, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
Tuesday, April 2, 2024 | USE AMENDMENT FILED |
Tuesday, April 2, 2024 | TEAS AMENDMENT OF USE RECEIVED |
Tuesday, April 2, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, January 4, 2024 | ASSIGNED TO EXAMINER |
Monday, April 22, 2024 | USE AMENDMENT ACCEPTED |
Monday, April 22, 2024 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
Tuesday, April 23, 2024 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
Tuesday, May 28, 2024 | REGISTERED-SUPPLEMENTAL REGISTER |
Tuesday, May 28, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |